HIV-1 drug resistance transmission networks in Southwest Switzerland

AIDS Research and Human Retroviruses

Volumn 26, Issue 11, 2010, Pages 1233-1238

  Castro, Erika ^a   Khonkarly, Mona ^a   Ciuffreda, Donatella ^a   Bürgisser, Philippe ^a   Cavassini, Matthias ^a   Yerly, Sabine ^b   Pantaleo, Giuseppe ^a   Bart, Pierre Alexandre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CLADISTICS; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRUCTURAL GENE; SWITZERLAND; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN; VIRUS TRANSMISSION;

CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SWITZERLAND;

EID: 78649280326     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0083     Document Type: Article

References (10)

1. Yerly S, von Wyl V, Ledergerber B, Böni J, et al.: Transmission of HIV-1 drug resistance in Switzerland: A 10-year molecular epidemiology survey. AIDS 2007;21:2223-2229.
2. Yerly S, Vora S, Rizzardi P, et al.: Acute HIV infection: Impact on the spread of HIV and transmission of drug resistance. AIDS 2001;15:2287-2292.
3. Eyer-Silva WA and Morgado MG. A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality. Mem Inst Oswaldo Cruz 2005;100:869-873.
4. Jost S, Yerly S, Kaufmann D, et al.: Spreading of a non-B recombinant form in seroconverting IVDU's [abstract]. Ninth Conference on Retroviruses and Opportunistic Infections 2002, Seattle; p. 17.
5. Korber B. HIV Signature and Sequence Variation Analysis. Computational Analysis of HIV Molecular Sequences, Chapter 4, Allen G. Rodrigo and Gerald H. Learn, eds. Dordrecht, Netherlands: Kluwer Academic Publishers. 2000;55-72.
6. Metzner KJ, Giulieri SG, Knoepfel SA, et al.: Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. Clin Infect Dis 2009;48:239-247.
7. Yerly S, Junier T, Gayet-Ageron A, et al.: The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS 2009;23:1415-1423.
8. Mahnke L and Clifford D. Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation. AIDS Res Ther 2006;3:21.
9. Bennett DE, Camacho RJ, Otelea D, et al.: Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE 2009;4:e4724.
10. Brumme ZL, Brumme CJ, Carlson J, et al.: Marked epitope and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008;82:9216-9227.